The Medicare Payment Advisory Committee (MedPAC) convened a session to examine access to hospice care and the provision of high-cost services, such as dialysis, radiation, blood transfusions, and chemotherapy, for Medicare beneficiaries with end-stage renal disease (ESRD) or cancer. Back in its April 2025 meeting, MedPAC staff presented initial results from an analysis of claims which showed that beneficiaries with… (Colocho, September 8, 2025) #Costs, #End of Life and Palliative Care, #End-Stage Renal Disease, #Hospice